IRadimed
- Market cap
- 1.09B
- P/E (TTM)i
- 47.75
- P/Bi
- 10.74
- EPSi
- 1.75
- Div yieldi
- 0.87%
- 52W posi
- 41%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 63.38% -0.02pp
- Institutions
- 261
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-01
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 16 buys · 34 sells
| Name | Role | Stake |
|---|---|---|
| Roger Susi | Chairperson & CEO | 34.32% |
| James Hawkins | Director | 0.23% |
| Monty Allen | Independent Director | 0.15% |
| John Glenn | Chief Financial Officer | 0.09% |
| Hilda Scharen-Guivel | Independent Director | 0.04% |
| Joseph Kiani | Director | 0.01% |
| Jeff Chiprin | -- | 0.01% |
| Anthony Vuoto | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-22 | Joseph Kiani | Director | Derivative Exercise and Retained | +698 | -- |
| 2026-09-02 | Monty Allen | Independent Director | Open Market Disposition | -1,419 | $86.35–86.44 |
| 2026-06-19 | John Glenn | Chief Financial Officer | Derivative Exercise and Sale | -2,319 | $92.20 |
| 2026-06-19 | John Glenn | Chief Financial Officer | Derivative Exercise and Retained | +3,477 | -- |
| 2026-06-03 | Hilda Scharen-Guivel | Independent Director | Open Market Disposition | -3,000 | $95.00 |
| 2026-05-31 | Roger Susi | Chairperson & CEO | Automatic Disposition | -2,500 | $88.68–91.91 |
| 2026-05-26 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $91.81–92.93 |
| 2026-05-18 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $85.95–88.65 |
| 2026-05-11 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $83.70–85.90 |
| 2026-05-04 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $83.78–87.31 |
| 2026-04-27 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $84.13–89.70 |
| 2026-04-20 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $89.73–93.90 |
| 2026-04-13 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $91.84–94.55 |
| 2026-04-06 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $94.36–96.78 |
| 2026-03-29 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $94.81–96.53 |
| 2026-03-23 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $99.58–102.02 |
| 2026-03-16 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $101.18–102.43 |
| 2026-03-09 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $100.04–100.11 |
| 2026-03-05 | Roger Susi | Chairperson & CEO | Automatic Disposition | -7,500 | $98.25–99.12 |
| 2026-03-02 | John Glenn | Chief Financial Officer | Other Derivative Acquisition | +8,907 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:09:21 · For reference only, not investment advice and not tailored to your situation.